We are grateful to our early investors of The o2h Therapeutics and AI EIS Fund and should they wish to increase their participation in the upcoming deals we have put forward an offer for them to invest before the end of the tax year on April 5th with a 50% reduction in the initial fee from 4% to 2%. If any of our existing investors wish to refer us to other friends, family or colleagues then we shall be able to also offer them an opportunity to invest at the reduced initial fee of 2% as well as offer the referrer a ticket to a high level-sporting event.

If you are an existing investor and wish to top-up your current invested amount, send us an email at invest@o2h.com.

New investors may register by following this link- https://o2h.com/ventures

Sunil Shah, Managing Partner at o2h Ventures Ltd commented “We are really excited to launch the o2h ventures therapeutics fund. We see great deal flow through our hot network which is an accumulation of over 15 years of providing research services to this sector. The EIS benefits are a great way to invest in these fledgling businesses and access great British innovation in therapeutics whilst mitigating the risk through the tax benefits. We look forward to making our first investment in early 2019.”

For further queries and details, mail us at ajit@o2h.com